Tobias Grabe
Dortmund, NW 44227, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2.
Journal: RSC medicinal chemistry
Published: January 17, 2024
Addressing the Osimertinib Resistance Mutation EGFR-L858R/C797S with Reversible Aminopyrimidines.
Journal: ACS medicinal chemistry letters
Published: December 08, 2022
A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2.
Journal: RSC medicinal chemistry
Published: June 17, 2022
Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing Inhibitors.
Journal: Journal of medicinal chemistry
Published: April 29, 2022
Targeting Her2-insYVMA with Covalent Inhibitors-A Focused Compound Screening and Structure-Based Design Approach.
Journal: Journal of medicinal chemistry
Published: September 15, 2020
Complex Crystal Structures of EGFR with Third-Generation Kinase Inhibitors and Simultaneously Bound Allosteric Ligands.
Journal: ACS medicinal chemistry letters
Published: August 26, 2020
Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797S.
Journal: Chemical science
Published: July 12, 2019
C797S Resistance: The Undruggable EGFR Mutation in Non-Small Cell Lung Cancer?
Journal: ACS medicinal chemistry letters
Published: August 22, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026